Pharmacoeconomics: overview

Payers of health care systems in each country have to be convinced that new treatment options provide additional benefit. New drugs are expected to have a more favorable efficiency, risk profile with at least comparable financial load. Since clinical trial results are primarily focused on efficiency and safety, additional efforts are to be made to bring in economic rationale in your company’s message. Economic evaluations are carried out alongside randomized controlled trials and are aiming to collect arguments to support company’s claims.

But the final message is not universal around the target markets and is strongly affected by local specifics. That’s where we can help you translate clinical results and economic evaluations of your newly approved molecule into tangible opportunities for health care providers and benefits for local payers.

These benefits come in many facets: a minimization on current expenses, better outcomes for patients, more favorable utility parameters, etc. To recognize the winning arguments and rediscover their persuasive power we cooperate with national opinion leaders in Pharmacoeconomics who provide analytics in the form of expert estimations, conclusions and reviews. Such materials can be utilized by your regulatory specialists for compiling national drug registration dossier or enlisting your product in all kinds of national, regional and institutional purchase lists. Your local marketing personnel might tailor their promotional efforts pointing out favorable Pharmacoeconomics.

You can order this service from us as part of your localized commercialization strategy. Negotiating target market access, optimal pricing and reimbursement are critical challenges for manufacturers as they seek to achieve acceptable levels of return on investment after lengthy and costly development programs. Commercialization, particularly the evidence requirements of payers, has to be planned and integrated into development pipeline.

We can perform review of label claims according to the needs of local markets and help prioritize indications. We examine targeted economic needs and shape selected messages. On your behalf we can order and generate localized Health Economic Modeling, Data Analytics, prepare Country Value Dossiers, Reimbursement submissions and Strategic Payer Communications.

Our expertise will help you align discovered clinical evidence and evaluated economic parameters with pricing, reimbursement and access strategies for local markets.